New combo pill shows promise for diabetes control over one year
NCT ID NCT02220907
First seen Jan 09, 2026 · Last updated May 09, 2026 · Updated 18 times
Summary
This study tested a once-daily combination pill (MT-2412) containing two diabetes drugs, Teneligliptin and Canagliflozin, in 153 Japanese adults with type 2 diabetes whose blood sugar was not well controlled on Teneligliptin alone. Over 52 weeks, researchers monitored safety and measured changes in HbA1c and fasting glucose levels. The goal was to see if the combo could help manage diabetes long-term, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research site
Chugoku, Japan
-
Research site
Chūbu, Japan
-
Research site
Hokkaido, Japan
-
Research site
Kanto, Japan
-
Research site
Kyushu, Japan
-
Research site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.